WGS
GeneDx Holdings Corp.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$101.10
−3.67%Forward multiples
Based on analyst estimates
- P/E forward
- 154.27x
- P/E 2026E
- 999.00x
- P/E 2027E
- 85.48x
- P/E 2028E
- 54.39x
- P/S forward
- 5.59x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 12.35x
- Price / sales
- 6.63x
- Price / cash flow
- -61.90x
Enterprise value
- Enterprise value
- $3.0B
- EV / sales
- 6.71x
- EV / EBITDA
- -39.90x
- EV / EBIT
- -50.32x
- Market cap
- $3.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026